Accendra HealthACH +0.28%61 3-Year ROIIC % is 3.32 as of Dec. 2025. GuruFocus rates ACH with a GF Score™ of 61/100 and a GF Value™ of $5.02 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 113 Medical Distribution companies, Accendra Health ranks better than 52.21% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Accendra Health's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 3.32%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Accendra Health's 3-Year ROIIC % or its related term are showing as below:
ACH's 3-Year ROIIC % is ranked better than 52.21% of 113
companies
in the Medical Distribution industry
Industry Median: 2.2
vs ACH: 3.32
Accendra Health (NYSE:ACH) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Accendra Health 3-Year ROIIC % Related Terms
Accendra Health 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Accendra Health's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Accendra Health's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accendra Health 3-Year ROIIC % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Accendra Health's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Accendra Health's 3-Year ROIIC % falls into.
Accendra Health's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 221.739 (Dec. 2025) - 276.782 (Dec. 2022) )
/
( 2417.974 (Dec. 2025) - 4076.106 (Dec. 2022) )
=
-55.043
/
-1658.132
=
3.32%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Accendra Health (ACH) has a 3-Year ROIIC % of 3.32 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Accendra Health and its competitors. According to the industry distribution chart, Accendra Health ranks #54 out of 113 companies in the Medical Distribution industry, placing it in the top 47.8%.
Is Accendra Health's 3-Year ROIIC % too high?
Accendra Health's current 3-Year ROIIC % is 3.32. The Medical Distribution industry median 3-Year ROIIC % is 2.20. Accendra Health's value of 3.32 is 50.9% above this industry median. Based on the distribution chart, Accendra Health ranks #54 out of 113 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Accendra Health has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Accendra Health's 3-Year ROIIC % compare to FOCL and YI?
According to the Medical Distribution industry distribution chart, Accendra Health ranks #54 out of 113 companies for 3-Year ROIIC %. This puts Accendra Health in the upper half of its industry. The industry median 3-Year ROIIC % is 2.20. Accendra Health's value of 3.32 is 50.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Distribution company?
The median 3-Year ROIIC % among Medical Distribution companies is 2.20, based on 113 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Accendra Health's current 3-Year ROIIC % of 3.32 is 50.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Accendra Health and its competitors. For the Medical Distribution industry, the median 3-Year ROIIC % is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accendra Health's current 3-Year ROIIC % is 3.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accendra Health stock overvalued right now?
Based on GuruFocus' analysis, Accendra Health (ACH) is currently considered Modestly Undervalued. The stock's GF Value™ is $5.02, compared to a current price of $3.59 — trading 28.5% below its estimated fair value. The current 3-Year ROIIC % is 3.32 and 50.9% above the Medical Distribution industry median of 2.20. Accendra Health's overall GF Score™ is 61/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Accendra Health (ACH), the current 3-Year ROIIC % is 3.32 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Accendra Health (ACH) Overvalued in 2026?
Based on GuruFocus' analysis, Accendra Health stock appears to be undervalued.
The current stock price of $3.59 is trading 28.5% below its estimated GF Value™ of $5.02.
GuruFocus considers Accendra Health to be Modestly Undervalued.
Key valuation signals for ACH:
3-Year ROIIC %: 3.32
GF Value™: $5.02 vs. price of $3.59 (28.5% below fair value)
Industry Position: 50.9% above the Medical Distribution median (#54 of 113)
No single metric tells the full story. See the ACH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
61GF Score
Get the complete analysis for ACH
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ACH has been successfully added to your 
